The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Jan Hedenbro

Jan Hedenbro

Visiting research fellow

Jan Hedenbro

Clinical Indications, Utilization, and Funding of Bariatric Surgery in Europe

Author

  • Oleg Borisenko
  • Zeynep Colpan
  • Bruno Dillemans
  • Peter Funch-Jensen
  • Jan Hedenbro
  • Ahmed R. Ahmed

Summary, in English

The objective of this study was to evaluate the current utilization, the level of endorsement by professional societies, and health technology assessment bodies, as well as the reimbursement levels for bariatric surgery in European countries. We performed an analysis of the indications for bariatric surgery based on national clinical and commissioning guidelines, current utilization of surgery, characteristics of patients who underwent surgery, and reimbursement tariffs in Belgium, Denmark, England, France, Germany, Italy, and Sweden. Data were obtained from national patient registries, administrative databases, and published literature for the year 2012. Despite clear consensus outlined in clinical guidelines, significant differences were found in the eligibility criteria for surgery. Patients with no significant comorbidities were deemed eligible if they had a body mass index (BMI) of 40 or 50 kg/m(2) in Denmark. Irrespective of the country, patients with comorbidities were eligible if they had a BMI of 35 kg/m(2). The highest utilization of bariatric surgery (number of surgeries per 1 M population) was observed in Belgium (928), Sweden (761), and France (571) while Italy (128), England (117), and Germany (72) had the lowest utilization. There was a strong negative correlation between utilization and average BMI level of the patient population (r = -.909, p = 0.005). The annual per capita spending on surgery differed significantly between countries, ranging from a,not sign0.54 in Germany to a,not sign4.33 in Belgium. There are significant variations in the clinical indications, utilization, and funding of bariatric surgery in European countries.

Department/s

  • Neuroendocrine Cell Biology

Publishing year

2015

Language

English

Pages

1408-1416

Publication/Series

Obesity Surgery

Volume

25

Issue

8

Document type

Journal article

Publisher

Springer

Topic

  • Surgery

Keywords

  • Bariatric surgery
  • Clinical indication
  • Reimbursement
  • Utilization
  • Health care policy

Status

Published

Research group

  • Neuroendocrine Cell Biology

ISBN/ISSN/Other

  • ISSN: 1708-0428